Skip to main content Skip to accessibility
This website is not compatible with your web browser. You should install a newer browser. If you live in Jersey and need help upgrading call the States of Jersey web team on 440099.
Government of Jerseygov.je

Information and public services for the Island of Jersey

L'înformâtion et les sèrvices publyis pouor I'Île dé Jèrri

  • Choose the service you want to log in to:

  • gov.je

    Update your notification preferences

  • one.gov.je

    Access government services

  • CAESAR

    Clear goods through customs or claim relief

  • Talentlink

    View or update your States of Jersey job application

Prescribed List: Changes from 1 December 2014

A formal published “Ministerial Decision” is required as a record of the decision of a Minister (or an Assistant Minister where they have delegated authority) as they exercise their responsibilities and powers.

Ministers are elected by the States Assembly and have legal responsibilities and powers as “corporation sole” under the States of Jersey Law 2005 by virtue of their office and in their areas of responsibility, including entering into agreements, and under any legislation conferring on them powers.

An accurate record of “Ministerial Decisions” is vital to effective governance, including:

  • demonstrating that good governance, and clear lines of accountability and authority, are in place around decisions-making – including the reasons and basis on which a decision is made, and the action required to implement a decision

  • providing a record of decisions and actions that will be available for examination by States Members, and Panels and Committees of the States Assembly; the public, organisations, and the media; and as a historical record and point of reference for the conduct of public affairs

Ministers are individually accountable to the States Assembly, including for the actions of the departments and agencies which discharge their responsibilities.

The Freedom of Information Law (Jersey) Law 2011 is used as a guide when determining what information is be published. While there is a presumption toward publication to support of transparency and accountability, detailed information may not be published if, for example, it would constitute a breach of data protection, or disclosure would prejudice commercial interest.

A decision made 28 October 2014:

Decision Reference: MD-S-2014-0135

Decision Summary Title :

Prescribed List Changes 1 December 2014

Date of Decision Summary:

27 October 2014

Decision Summary Author:

Prescribing Advisor

Decision Summary:

Public or Exempt?

Public

Type of Report:

Oral or Written?

Written

Person Giving

Oral Report:

N/A

Written Report

Title :

Changes to be made to the Prescribed List as at 1 December 2014

Date of Written Report:

27 October 2014

Written Report Author:

Prescribing Advisor

Written Report :

Public or Exempt?

Exempt clause 3.2.1 (a) (xi)

Subject: Changes to be made to the Prescribed List (Jersey) as at 1 December 2014

Decision(s): Further to Article 15, paragraphs (11) and (12), of the Health Insurance (Jersey) Law 1967, and having consulted with the Pharmaceutical Benefit Advisory Committee, the Minister decided to make amendments to the Prescribed List. The Minister added chlortalidone table 50mg for the treatment of high blood pressure, and Renavit multivitamin tablet for the prevention of vitamin deficiency in patients on renal dialysis. The Minister also supported the preferential use of venlafaxine modified-release tablets instead of capsules, the use of Fencino brand of fentanyl patch on a trial basis, and the exclusive reimbursement of Laxido brand of macrogol powder.

 

Furthermore, following recommendations by the Pharmaceutical Benefit Advisory Committee on 10 October 2013 and 15 July 2014, respectively, the Minister has added a specified range of oral contraceptives and long-acting reversible contraceptives, to the Prescribed List.

 

These changes will have effect from 1 December 2014.

Reason(s) for Decision:

The Pharmaceutical Benefit Advisory Committee (PBAC) met on 30 September 2014 and has provided the Minister with a written report setting out its recommendations in respect of amendments to the Prescribed List.  Furthermore, the changes reflect current evidence and expert advice, and ensure that patients in Jersey have access to an appropriate range of modern, safe and effective treatments from their GPs at a proportionate cost to the Fund.

Resource Implications:   The overall impact of the changes represents an anticipated cost to the Fund of around £75,000 per annum.

Action required:  Policy Principal to issue public notice listing amendments and notify all approved medical practitioners and approved contractors.

Signature:

 

Position:

Minister

Date Signed:

 

 

Date of Decision (If different from Date Signed):

 

Back to top
rating button